NVO
Novo-Nordisk A/SstockNYSEADR
At CloseNov 20, 2026 4:00:00 PM EST
37.81USD-2.727%(-1.06)13,069,377
Pre-marketNov 20, 2026 9:28:30 AM EST
38.41USD-1.183%(-0.46)
After-hoursNov 20, 2026 4:57:30 PM EST
37.90USD+0.238%(+0.09)
Loading…
Loading…
166.69B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$38.87
Beta
0.92
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$39.59
SMA 200
$42.88
Avg. Vol 10D
13.92M
Avg. Vol 30D
12.09M
Avg. Vol 90D
12.68M
Relative Vol
1.08
4.41B
3.16B
71.60%
38,286,865
1.21%
4.04
54%/46%
36.59%
20.39%
0.2800%
10,000,000
12
19,458
121,034
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Nov 21, 2026
Novo Nordisk's Wegovy Pill Is Capturing 80% of New Oral Obesity Prescriptions. Is NVO Stock a Buy? ·
The Motley Fool+1 source
Novo Nordisk Stock: The AI Case Wall Street May Be Missing ·
InvestorPlace
Nov 20, 2026
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 41.63 | 2026-11-13 | -9.15% | -0.134 |
| 1M | 39.06 | 2026-10-21 | -3.17% | 0.821 |
| 3M | 46.74 | 2026-08-21 | -19.08% | 0.634 |
| 6M | 44.39 | 2026-05-21 | -14.80% | 0.285 |
| 1Y | 47.63 | 2025-11-21 | -20.60% | 0.922 |
| 2Y | 102.63 | 2024-11-21 | -63.15% | — |
| 5Y | 55.62 | 2021-11-22 | -32.00% | 0.672 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $37.82, and today's volume is 13,069,377. NVO is down 2.701% today. The 30 day average volume is 12.09M. NVO market cap is $166.69B with 4.41B shares outstanding.
